• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Genotyping to Guide Antiplatelet Therapy for the Secondary Prevention of Lacunar Strokes.

作者信息

Sposato Luciano A, Donnan Geoffrey Alan

机构信息

From the Department of Clinical Neurological Sciences (L.A.S.), Schulich School of Medicine and Dentistry, Heart & Brain Laboratory (L.A.S.), Departments of Epidemiology and Biostatistics and Anatomy and Cell Biology (L.A.S.), Schulich School of Medicine and Dentistry, Robarts Research Institute (L.A.S.), Western University; Lawson Health Research Institute (L.A.S.), London, Ontario, Canada; Department of Neurology (G.A.D.), Melbourne Brain Centre, The Royal Melbourne Hospital; and Faculty of Medicine Dentistry and Health Sciences (G.A.D.), The University of Melbourne, Parkville, Australia.

出版信息

Neurology. 2023 Apr 18;100(16):741-743. doi: 10.1212/WNL.0000000000206898. Epub 2023 Jan 25.

DOI:10.1212/WNL.0000000000206898
PMID:36697243
Abstract
摘要

相似文献

1
Genotyping to Guide Antiplatelet Therapy for the Secondary Prevention of Lacunar Strokes.基因分型指导腔隙性脑卒中介入预防的抗血小板治疗
Neurology. 2023 Apr 18;100(16):741-743. doi: 10.1212/WNL.0000000000206898. Epub 2023 Jan 25.
2
CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study.CYP2C19代谢状态与氯吡格雷在小皮层下卒中二级预防（SPS3）研究中的疗效
J Am Heart Assoc. 2015 May 27;4(6):e001652. doi: 10.1161/JAHA.114.001652.
3
Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial.基于细胞色素 P450 2C19 基因分型的三氟柳与氯吡格雷在脑卒中二级预防中比较的方案（MASETRO 研究）：一项多中心、随机、开放标签、平行组试验。
Int J Stroke. 2016 Jun;11(4):485-91. doi: 10.1177/1747493015620804. Epub 2016 Jan 5.
4
Cost-effectiveness of CYP2C19 genotyping to guide antiplatelet therapy for acute minor stroke and high-risk transient ischemic attack.CYP2C19 基因分型指导急性小卒中和高危短暂性脑缺血发作抗血小板治疗的成本效益。
Sci Rep. 2021 Apr 1;11(1):7383. doi: 10.1038/s41598-021-86824-9.
5
Prospective Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical Trial.经皮冠状动脉介入治疗后前瞻性基因分型指导抗血小板治疗：一项实用随机临床试验。
Circ Genom Precis Med. 2020 Feb;13(1):e002640. doi: 10.1161/CIRCGEN.119.002640. Epub 2020 Jan 12.
6
The role of genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack.基因分型在缺血性卒中和短暂性脑缺血发作后指导抗血小板治疗中的作用。
Expert Rev Clin Pharmacol. 2022 Jul;15(7):811-825. doi: 10.1080/17512433.2022.2108401. Epub 2022 Aug 4.
7
Prevalence of carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setup.沙特缺血性脑卒中患者携带者的流行情况，以及在大学医院环境下使用基因分型指导抗血小板治疗的适宜性。
Drug Metab Pers Ther. 2021 Jul 8;37(1):35-40. doi: 10.1515/dmpt-2021-0104.
8
Comparison of a rapid point-of-care and two laboratory-based CYP2C19*2 genotyping assays for personalisation of antiplatelet therapy.用于抗血小板治疗个体化的即时快速检测与两种基于实验室的CYP2C19*2基因分型检测方法的比较
Int J Clin Pharm. 2016 Apr;38(2):414-20. doi: 10.1007/s11096-016-0269-6. Epub 2016 Mar 15.
9
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.CYP2C19*17 等位基因对经皮冠状动脉介入治疗后接受基于基因型的抗血小板治疗患者结局的影响。
Clin Pharmacol Ther. 2021 Mar;109(3):705-715. doi: 10.1002/cpt.2039. Epub 2020 Oct 2.
10
Clopidogrel responder status is uninfluenced by CYP2C19*2 in Danish patients with stroke.氯吡格雷反应状态不受 CYP2C19*2 影响在丹麦中风患者中。
PLoS One. 2020 Dec 28;15(12):e0236260. doi: 10.1371/journal.pone.0236260. eCollection 2020.